Once a lead molecule is identified, it undergoes rigorous pharmacological evaluation to refine its profile and assess safety.
Once a lead compound is identified, it enters the preclinical phase. Here, pharmacology answers two critical questions: What does the drug do to the body? and What does the body do to the drug? pharmacology in drug discovery and development
[Target Identification] ➔ [Target Validation] ➔ [Hit-to-Lead Screening] ➔ [Lead Optimization] ➔ [Candidate Selection] 1. Target Identification and Validation Once a lead molecule is identified, it undergoes
Once a lead molecule is identified, it undergoes rigorous pharmacological evaluation to refine its profile and assess safety.
Once a lead compound is identified, it enters the preclinical phase. Here, pharmacology answers two critical questions: What does the drug do to the body? and What does the body do to the drug?
[Target Identification] ➔ [Target Validation] ➔ [Hit-to-Lead Screening] ➔ [Lead Optimization] ➔ [Candidate Selection] 1. Target Identification and Validation